Avita Medical Enters into Joint Venture to Expand Sales of ReCell® Spray-On Skin(TM) Throughout the Middle East and North Africa

NORTHRIDGE, Calif. & CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Avita Medical Ltd. (ASX: AVH), the regenerative medicine company, announced that it has entered into a Joint Venture partnership with Kuwait-based MENA United Ltd. to pursue sales and marketing of Avita Medical’s regenerative product ReCell Spray-On Skin throughout the region of the Middle East and North Africa (MENA).

Back to news